Jak wyniki badań klinicznych wpływają na aktualizację wskazań i zaleceń? Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2009
Słowa kluczowe:
badanie kliniczne, klasy zaleceń, poziom dowodów
##plugins.themes.bootstrap3.article.main##
Abstrakt
Wyniki badań klinicznych przekładają się na rejestracje dla leków i zalecenia w standardach postępowania. Kolejne dane powodują dla nich zmiany w klasach zaleceń i poziomach dowodów. W artykule na kilku przykładach leków kardiologicznych przedstawiono to zagadnienie.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Grabowski , M. (2009). Jak wyniki badań klinicznych wpływają na aktualizację wskazań i zaleceń? . Medycyna Faktów , 2(3(4), 80-84. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2652
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Grabowski M., Filipiak K.J.: Evidence Based Medice na przykładzie badań z lekami hipolipemizującymi – 44 pytania i odpowiedzi. Medical Education, Warszawa 2008: 1-81.
2. Heart Protection Study Collaborative Group (writing committee: Collins R., Armitage J., Parish S., Sleight, Peto R.): MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. The CURE Trial Investigators. N. Engl. J. Med. 2001; 345: 494-502.
4. Bassand J.P., Hamm C.W., Ardissino D. et al.: The Task Force of Diagnosis and Treatment of Non-ST-segment Elecation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007; Jul.; 28(13): 1598-660. Epub 2007; Jun. 14.
5. Anderson J.L., Adams C.D., Antman E.M. et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2007; Aug. 14; 50(7): e1-e157. Erratum in: J. Am. Coll. Cardiol. 2008; Mar. 4; 51(9): 974.
6. Van de Werf F., Bax J., Betriu A. et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart. J. 2008; Dec.; 29(23): 2909-45.
7. Antman E.M., Hand M., Armstrong P.W. et al.: 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008, Jan. 15; 51(2): 210-47. Review. Erratum in: J. Am. Coll. Cardiol. 2008, Mar. 4; 51(9): 977.
8. Sabatine M.S., Cannon C.P., Gibson C.M. et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Eng. J. ed.. 2005; 352: 1179-1189.
9. Chen Z.M. et al.: Prezentacja podczas kongresu ACC 2005.
10. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.
2. Heart Protection Study Collaborative Group (writing committee: Collins R., Armitage J., Parish S., Sleight, Peto R.): MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. The CURE Trial Investigators. N. Engl. J. Med. 2001; 345: 494-502.
4. Bassand J.P., Hamm C.W., Ardissino D. et al.: The Task Force of Diagnosis and Treatment of Non-ST-segment Elecation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007; Jul.; 28(13): 1598-660. Epub 2007; Jun. 14.
5. Anderson J.L., Adams C.D., Antman E.M. et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2007; Aug. 14; 50(7): e1-e157. Erratum in: J. Am. Coll. Cardiol. 2008; Mar. 4; 51(9): 974.
6. Van de Werf F., Bax J., Betriu A. et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart. J. 2008; Dec.; 29(23): 2909-45.
7. Antman E.M., Hand M., Armstrong P.W. et al.: 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008, Jan. 15; 51(2): 210-47. Review. Erratum in: J. Am. Coll. Cardiol. 2008, Mar. 4; 51(9): 977.
8. Sabatine M.S., Cannon C.P., Gibson C.M. et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Eng. J. ed.. 2005; 352: 1179-1189.
9. Chen Z.M. et al.: Prezentacja podczas kongresu ACC 2005.
10. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.